Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Debt to Equity (2018 - 2026)

Rockwell Medical filings provide 10 years of Debt to Equity readings, the most recent being $0.24 for Q4 2025.

  • On a quarterly basis, Debt to Equity fell 28.31% to $0.24 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.24, a 28.31% decrease, with the full-year FY2025 number at $0.24, down 28.31% from a year prior.
  • Debt to Equity hit $0.24 in Q4 2025 for Rockwell Medical, down from $0.28 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $8.11 in Q4 2021 to a low of -$3.83 in Q1 2022.
  • Median Debt to Equity over the past 5 years was $0.51 (2023), compared with a mean of $0.77.
  • Biggest five-year swings in Debt to Equity: soared 1223.35% in 2021 and later plummeted 572.62% in 2022.
  • Rockwell Medical's Debt to Equity stood at $8.11 in 2021, then tumbled by 91.97% to $0.65 in 2022, then fell by 22.16% to $0.51 in 2023, then plummeted by 34.36% to $0.33 in 2024, then decreased by 28.31% to $0.24 in 2025.
  • The last three reported values for Debt to Equity were $0.24 (Q4 2025), $0.28 (Q3 2025), and $0.37 (Q2 2025) per Business Quant data.